Cardisio logo — Your heart counts

Cardisio

Your heart counts

Founded 2016 Germany Germany 41 employees Grant Total: $8.84M AI, Health Care +2

General Information

Company Name Cardisio
Founded Year 2016
Location Germany Germany
Employees 41
Industries AI, Health Care, Health and Wellness +1
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Cardisio. To contact Cardisio, visit cardis.io.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Cardisio

Cardisio is a Germany-based Health Care startup founded in 2016 with a mission epitomized by their slogan, "Your heart counts." The company aims to tackle the significant challenge of reducing unnecessary deaths, impaired quality of life, and medical expenses associated with heart disease. Their solution, Cardisiography, utilizes AI-based 3D-vectorcardiography to enable easy detection of pathological signs of arterial and structural heart diseases. The innovative technology boasts a sensitivity of more than 90%, surpassing conventional first-line diagnostics. The company has recently secured a £342.48K grant investment from SBRI Healthcare on 17 January 2023. Overall, Cardisio's approach to early heart disease screening shows promise in bringing about a substantial positive impact on public health. For more detailed information about the product and the company, please visit Cardisio's website.

Taxonomy: AI-based technology, 3D-vectorcardiography, Heart disease screening, Early detection, Arterial diseases, Structural heart diseases, Medical diagnostics, Healthcare innovation, Health technology, Cardiovascular health, Medical technology, Healthcare solutions

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant £342.48K 1
SBRI Healthcare
17 Jan 2023
Venture Round €5.00M 1
LEA Partners
02 Jul 2022
Seed Round €3.50M 2
Shawn O'Neill, Jim Davidson
19 Oct 2021

Cardisio Alternatives & Competitors

Cardisio vs
Cytovale
Cytovale United States

At Cytovale, we’re focused on more rapid and insightful ways to diagnose fast-moving and immune-medi...

Series C
121 employees
AI, Health Care
Cardisio vs

Millions of ECGs are performed every week with technology that hasn't changed in 50 years. We intend...

Debt Financing
20 employees
AI, Health Care
Cardisio vs
LightHearted AI
LightHearted AI United Kingdom

AI-powered Remote Cardiovascular Diagnostics

Non Equity Assistance
7 employees
AI, Health Care

FAQ About Cardisio

Your heart counts
Cardisio was founded in 2016.
Cardisio is headquartered in Germany.
Cardisio operates in AI, Health Care, Health and Wellness and Sports. Its work centres on AI-based technology, 3D-vectorcardiography, Heart disease screening and Early detection.
Cardisio has approximately 41 employees.
Cardisio has completed 3 funding rounds, raising a total of $8.84M. The latest funding stage is Grant.
Top alternatives and competitors to Cardisio include Cytovale, HeartSciences (NASDAQ:HSCS), LightHearted AI, AIRAmed GmbH, Caption Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cardisio and Cytovale are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cardisio, https://bouncewatch.com/company/cardisio, updated 19 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes